TOVX financials
Theriva Biologics (TOVX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TOVX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$24.05M | -$25.25M | -2.08 |
| 2024 | – | – | -$26.35M | -$25.65M | -19.03 |
| 2023 | – | – | -$21.43M | -$18.35M | -28.48 |
| 2022 | – | – | -$21.58M | -$20.02M | -32.75 |
| 2021 | – | – | -$14.27M | -$23.19M | -47.50 |
| 2020 | – | – | -$10.16M | -$12.56M | -165.00 |